Laboratory Testing in the Treatment of HCV: New Drugs, New Tests, New Rules
Description: Douglas T. Dieterich, MD discusses which will focus on current guidelines and recommended strategies for treating patients with chronic hepatitis C viral (HCV) infection, including protease inhibitors and response-guided therapy, HCV RNA assays, IL28B genotyping and resistance testing.
Learning objectives: at the conclusion of this activity, participants will be able to:
o Discuss the epidemiology and current disease trends for hepatitis C infection in the United States
o Communicate current treatment guidelines and recommended strategies for treating HCV, including newly developed protease inhibitors
o Describe recommended laboratory testing for screening and managing patients with HCV